COVID-19 Vaccines in Children
- PMID: 38202094
- PMCID: PMC10779890
- DOI: 10.3390/jcm13010087
COVID-19 Vaccines in Children
Abstract
The COVID-19 pandemic has left an indelible mark on global health, affecting individuals of all ages across diverse communities. While the virus has predominantly been associated with severe outcomes in adults, its impact on children has garnered increasing attention. Today, three COVID-19 vaccines are available for use in the U.S. and recommended by the Advisory Committee on Immunization Practices (ACIP). As of September 2023, ongoing genomic surveillance identified SARS-CoV-2 XBB sublineages as the most common circulating SARS-CoV-2 variants, constituting over 99% of sequenced SARS-CoV-2 specimens in the US. Recently, recommendations for COVID-19 vaccination were updated accordingly to the 2023-2024 Omicron-XBB.1.5-adapted monovalent COVID-19 vaccine to provide heightened protection against currently circulating SARS-CoV-2 XBB-sublineage variants. COVID-19 vaccines have proven to be safe, efficacious, and effective at protecting against COVID-19 and preventing severe illness in children and adolescents.
Keywords: COVID-19; COVID-19 in children; COVID-19 vaccines; pediatric COVID-19.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36730051 Free PMC article.
-
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.MMWR Morb Mortal Wkly Rep. 2023 Oct 20;72(42):1140-1146. doi: 10.15585/mmwr.mm7242e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37856366 Free PMC article.
-
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1335-1342. doi: 10.15585/mmwr.mm7142a4. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36264840 Free PMC article.
-
COVID-19 vaccines in 2023.Aust Prescr. 2023 Oct;46(3):60-63. doi: 10.18773/austprescr.2023.020. Aust Prescr. 2023. PMID: 38053809 Free PMC article. Review.
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
Cited by
-
Maternal Vaccination and Neonatal Feeding Strategies Among Polish Women.Vaccines (Basel). 2025 Mar 31;13(4):376. doi: 10.3390/vaccines13040376. Vaccines (Basel). 2025. PMID: 40333255 Free PMC article.
-
The Ambivalence of Post COVID-19 Vaccination Responses in Humans.Biomolecules. 2024 Oct 17;14(10):1320. doi: 10.3390/biom14101320. Biomolecules. 2024. PMID: 39456253 Free PMC article. Review.
-
COVID-19 vaccination: challenges in the pediatric population.Front Public Health. 2025 Jan 29;12:1390951. doi: 10.3389/fpubh.2024.1390951. eCollection 2024. Front Public Health. 2025. PMID: 39944570 Free PMC article. Review.
-
Uncomplicated SARS-CoV-2 Infections with Preserved Lung Function in Pediatric Patients with Cystic Fibrosis: A Three-Year Single-Centre Experience.J Clin Med. 2025 Apr 25;14(9):2979. doi: 10.3390/jcm14092979. J Clin Med. 2025. PMID: 40364010 Free PMC article.
References
-
- Centers for Disease Control and Prevention COVID Data Tracker. [(accessed on 7 September 2023)]; Available online: https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
-
- Anderson E.J., Campbell J.D., Creech C.B., Frenck R., Kamidani S., Munoz F.M., Nachman S., Spearman P. Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral? Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2021;73:336–340. doi: 10.1093/cid/ciaa1425. - DOI - PMC - PubMed
-
- Siegel D.A., Reses H.E., Cool A.J., Shapiro C.N., Hsu J., Boehmer T.K., Cornwell C.R., Gray E.B., Henley S.J., Lochner K., et al. Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years—United States, August 2020–August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1249–1254. doi: 10.15585/mmwr.mm7036e1. - DOI - PMC - PubMed
-
- Delahoy M.J., Ujamaa D., Whitaker M., O’Halloran A., Anglin O., Burns E., Cummings C., Holstein R., Kambhampati A.K., Milucky J., et al. Hospitalizations Associated with COVID-19 among Children and Adolescents—COVID-NET, 14 States1 March 2020–14 August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1255–1260. doi: 10.15585/mmwr.mm7036e2. - DOI - PMC - PubMed
-
- Marks K.J., Whitaker M., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kirley P.D., Armistead I., McLafferty S., et al. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:271–278. doi: 10.15585/mmwr.mm7107e4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous